Sorted By:

Relevance


RA Report: Recognizing the Value of Innovation in the Treatment of Rheumatoid Arthritis

PhRMA  |  Report

In recent years, we have seen significant progress in our ability to diagnose and manage chronic diseases. Among autoimmune conditions such as rheumatoid arthritis (RA), lupus, and multiple sclerosis, treatment advances have played a major role in slowing disease progression, improving quality of...
https://www.phrma.org/report/ra-report-recognizing-the-value-of-innovation-in-the-treatment-of-rheumatoid-arthritis

BMJ clinical trial report misleading

PhRMA  |  Blog Post

  For example, the authors assert that only 67% of the reviewed studies were “timely” reported according to FDAAA standards.
http://catalyst.phrma.org/bmj-clinical-trial-report-misleading

Chart Pack: Cancer Medicines Value in Context

PhRMA  |  Report

Data and information found in this publication were drawn from a wide range of sources, including government agency reports, peer-reviewed journals, and the Pharmaceutical Research and Manufacturers of America’s (PhRMA’s) own research and analysis.
https://www.phrma.org/report/chart-pack-cancer-medicines-value-in-context

IMS Health Report Finds Medicines Helping Bend the Health Care Cost Curve

PhRMA  |  Press Release

But media reports often fail to acknowledge that there are inequities in insurance coverage for different types of health care services, and that chronically ill patients are often expected to pay more in out-of-pocket expenses for their medicines than for other types of health care, such as hospitalizations.
https://www.phrma.org/press-release/ims-health-report-finds-medicines-helping-bend-the-health-care-cost-curve

Medicines in Development for Skin Diseases 2011 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are currently developing 277 medicines to help the more than 100 million Americans—one-third of the U.S. population—afflicted with at least one skin disease, ranging from acne to melanoma. All of the medicines are either in clinical trials or awaitin...
https://www.phrma.org/report/medicines-in-development-for-skin-diseases

Medicines in Development for Mental Illnesses - 2012 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are developing 187 medicines to help the nearly 60 million American adults now suffering from some form of mental illness—from anxiety to depression and from schizophrenia to addictive disorders, such as dependence on alcohol or drugs. All of the med...
https://www.phrma.org/report/medicines-in-development-for-mental-illnesses-2012-report

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-phrma-report-medicines-in-development-for-patients-with-rare-diseases-demonstrate-the-promise-of-innovation

FDA approves a record 45 new medicines in 2015

PhRMA  |  Blog Post

Last year was an exceptionally strong year for biopharmaceutical innovation as the U.S. Food and Drug Administration (FDA) approved 45 new medicines – the highest number of approvals in almost two decades - giving patients even greater hope for the future. According to the ...
http://catalyst.phrma.org/fda-approves-a-record-45-new-medicines-in-2015

White House Healthcare Summit in Vermont Offers Opportunity for Input into Reform

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/white-house-healthcare-summit-in-vermont-offers-opportunity-for-input-into-reform

New Efforts to Spur Needed Civil Justice Reform

PhRMA  |  Blog Post

And, while there are no silver bullets, we hope the Caucus will be looking into promoting policies that protect companies that operate in compliance with applicable federal law; support state tort reform initiatives; and help judges to better use the rules and case management tools to reduce frivolous lawsuits and burdensome discovery.
http://catalyst.phrma.org/new-efforts-to-spur-needed-civil-justice-reform

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

This report’s focus is solely on investments made at clinical trial sites, and doesn’t capture all of the trial-wide work that occurs across sites, which includes things like trial design, coordination, and data analysis, nor does it capture the substantial investments companies make every year in basic and preclinical research, before projects ever get to the clinical testing phase.
http://catalyst.phrma.org/new-report-clinical-trials-and-the-impact-on-state-economies

PhRMA Statement on Health Care Reform Talks - 2009

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform-talks-2009

PhRMA Statement on Senate Health Care Reform Bill

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-senate-health-care-reform-bill1

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

PhRMA  |  Blog Post

The report also found patients faced higher average cost exposure for branded medicines as coinsurance and pharmacy deductibles evolve.
http://catalyst.phrma.org/new-report-confirms-competitive-market-works-net-prices-for-medicines-increased-just-2.8-percent-in-2015

PhRMA Statement on GAO Report

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-gao-report

A Big Step Forward in Patent Reform

PhRMA  |  Blog Post

Read our official statement on the passage of the America Invents Act.
http://catalyst.phrma.org/a-big-step-forward-in-patent-reform

PhRMA Statement on Secretary Burwell’s Delivery System and Payment Reform Announcement

PhRMA  |  Press Release

“Reflecting our commitment to advancing sound, patient-centered payment models, PhRMA recently released principles for payment and delivery system reform.
https://www.phrma.org/press-release/phrma-statement-on-secretary-burwell-s-delivery-system-and-payment-reform-announcement

2017 Direct to Consumer Advertising Survey Results

PhRMA  |  Report

This report covers the results of a survey conducted in April 2017 by Princeton Survey Research Associates International to learn about consumers' awareness of and opinions about direct to consumer advertisements of prescription medicines.
https://www.phrma.org/report/2017-direct-to-consumer-advertising-survey-results

Point of Sale Rebate Analysis in the Commercial Market

PhRMA  |  Report

This report by Milliman observes the reallocation in payer costs and member cost sharing relative to a baseline scenario across varying plan designs typically found in the employer market.
https://www.phrma.org/report/point-of-sale-rebate-analysis-in-the-commercial-market

PhRMA Statement on Patent Reform Act of 2009

PhRMA  |  Press Release

Industry-wide research and investment reached a record $58.8 billion in 2007.
https://www.phrma.org/press-release/phrma-statement-on-patent-reform-act-of-2009

PhRMA and The ALS Association Report More Than 560 Medicines in Development for Rare Diseases

PhRMA  |  Press Release

View the full report here: http://phrma.org/sites/default/files/pdf/medicines-in-development-report-rare-diseases.pdf   About PhRMAThe Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-and-the-als-association-report-more-than-560-medicines-in-development-for-rare-diseases

Budget Conferees Should Pursue Regular Order Process for Health Care Reform

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/budget-conferees-should-pursue-regular-order-process-for-health-care-reform

Scientific Progress Spurs Research Into Record Number of Cancer Medicines

PhRMA  |  Press Release

Industry-wide research and investment reached a record $67.4 billion in 2010.
https://www.phrma.org/press-release/scientific-progress-spurs-research-into-record-number-of-cancer-medicines

White House Healthcare Summit Offers Opportunity for Input into Reform

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/white-house-healthcare-summit-offers-opportunity-for-input-into-reform

Harry and Louise Return to Health Care Reform Debate with a New Perspective

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/harry-and-louise-return-to-health-care-reform-debate-with-a-new-perspective

You have reviewed the first 125 results out of 1029. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next